CurePharma Overview
- Year Founded
-
2019
- Status
-
Private
- Latest Deal Type
-
Later Stage VC
- Investors
-
1
CurePharma General Information
Description
Provider of regenerative medicine therapies designed for the treatment of neurodegenerative disorders and nervous system damage. The company provides cell reprogramming-based therapeutic approaches that enable the in situ conversion of supportive neural cells into functional neurons, providing disease-modifying solutions for patients with Parkinson's disease, retinal degeneration, stroke, spinal cord injury, and sensory impairment.
Contact Information
Corporate Office
- Hong Kong
- Hong Kong
Corporate Office
- Hong Kong
- Hong Kong
CurePharma Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 1. Later Stage VC | 01-Mar-2025 | Completed | Generating Revenue |
CurePharma Related Research & Analysis
Explore institutional-grade private market research from our team of analysts.
-
Verticals
CurePharma Investors (1)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| BVCF | Venture Capital | Minority |
CurePharma FAQs
-
When was CurePharma founded?
CurePharma was founded in 2019.
-
Where is CurePharma headquartered?
CurePharma is headquartered in Hong Kong, Hong Kong.
-
What industry is CurePharma in?
CurePharma’s primary industry is Drug Discovery.
-
Is CurePharma a private or public company?
CurePharma is a Private company.
-
What is CurePharma’s current revenue?
The current revenue for CurePharma is .
-
Who are CurePharma’s investors?
BVCF has invested in CurePharma.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process
